Stock TRUMY TERUMO CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Terumo Corporation OTC Markets

Equities

TRUMY

US88156J1051

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 01:29:59 08/06/2024 am IST 		5-day change 1st Jan Change
17.16 USD -0.69% Intraday chart for Terumo Corporation +1.00% +5.21%
28/05 Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System CI
15/05 Correction: Terumo’s Profit Up 47% in Fiscal 2024 MT

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 25,05,187 27,96,910 30,21,411 28,16,528 26,61,180 40,11,840 - -
Enterprise Value (EV) 1 26,07,340 28,76,206 30,81,210 28,37,273 27,05,795 40,51,918 39,58,859 38,86,541
P/E ratio 31.1 x 32.6 x 39.1 x 31.7 x 30 x 38.2 x 31.7 x 27.5 x
Yield 0.8% 0.75% 0.73% 0.91% 1.12% 0.81% 0.95% 1.05%
Capitalization / Revenue 4.18 x 4.45 x 4.92 x 4 x 3.24 x 4.4 x 4.05 x 3.77 x
EV / Revenue 4.35 x 4.57 x 5.02 x 4.03 x 3.3 x 4.4 x 4 x 3.65 x
EV / EBITDA 17.3 x 17.6 x 20.2 x 16.2 x 14.4 x 18.7 x 16.2 x 14.3 x
EV / FCF 79.7 x 103 x 69.6 x 45 x 46.3 x 59.7 x 46.6 x 36.6 x
FCF Yield 1.26% 0.97% 1.44% 2.22% 2.16% 1.68% 2.14% 2.73%
Price to Book 3.6 x 3.71 x 3.53 x 2.78 x 2.4 x 3.05 x 2.86 x 2.81 x
Nbr of stocks (in thousands) 14,82,359 15,03,715 15,11,083 15,12,636 14,89,189 14,84,767 - -
Reference price 2 1,690 1,860 2,000 1,862 1,787 2,702 2,702 2,702
Announcement Date 09/05/19 18/05/20 12/05/21 12/05/22 15/05/23 14/05/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,99,481 6,28,897 6,13,842 7,03,303 8,20,209 9,21,863 9,90,938 10,65,284
EBITDA 1 1,50,672 1,62,969 1,52,318 1,74,842 1,87,570 2,16,841 2,45,049 2,72,344
EBIT 1 1,06,637 1,10,611 98,386 1,15,960 1,17,332 1,40,096 1,66,903 1,91,908
Operating Margin 17.79% 17.59% 16.03% 16.49% 14.31% 15.2% 16.84% 18.01%
Earnings before Tax (EBT) 1 1,02,709 1,06,466 97,060 1,14,501 1,16,137 1,40,829 1,67,942 1,91,835
Net income 1 79,470 85,211 77,268 88,813 89,325 1,06,374 1,26,748 1,45,768
Net margin 13.26% 13.55% 12.59% 12.63% 10.89% 11.54% 12.79% 13.68%
EPS 2 54.35 56.98 51.16 58.72 59.50 71.50 85.29 98.21
Free Cash Flow 1 32,726 27,969 44,277 63,013 58,415 67,904 84,900 1,06,090
FCF margin 5.46% 4.45% 7.21% 8.96% 7.12% 7.37% 8.57% 9.96%
FCF Conversion (EBITDA) 21.72% 17.16% 29.07% 36.04% 31.14% 31.32% 34.65% 38.95%
FCF Conversion (Net income) 41.18% 32.82% 57.3% 70.95% 65.4% 63.84% 66.98% 72.78%
Dividend per Share 2 13.50 14.00 14.50 17.00 20.00 22.00 25.67 28.50
Announcement Date 09/05/19 18/05/20 12/05/21 12/05/22 15/05/23 14/05/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 3,07,278 2,83,296 1,72,921 3,44,637 1,78,845 1,79,821 1,97,340 2,05,976 4,03,316 2,14,677 2,02,216 2,15,252 2,28,622 4,43,874 2,39,077 2,38,912 2,41,745 2,50,140 2,59,690 2,57,431
EBITDA 1 - - - - - - - - - - - - - - - 55,177 62,112 63,149 59,607 60,532
EBIT 1 59,150 41,824 29,624 65,857 28,598 21,505 30,427 25,550 55,977 37,537 23,121 29,644 36,848 66,492 39,027 34,577 39,994 43,350 45,026 42,014
Operating Margin 19.25% 14.76% 17.13% 19.11% 15.99% 11.96% 15.42% 12.4% 13.88% 17.49% 11.43% 13.77% 16.12% 14.98% 16.32% 14.47% 16.54% 17.33% 17.34% 16.32%
Earnings before Tax (EBT) 1 58,065 40,659 29,262 65,282 27,762 21,457 29,667 24,957 54,624 37,476 24,037 29,804 36,624 66,428 39,315 35,086 40,363 43,825 43,762 43,120
Net income 1 45,711 31,842 22,093 49,988 21,708 17,117 22,398 17,923 40,321 29,859 19,145 22,549 27,543 50,092 29,805 26,477 30,328 32,806 33,779 32,630
Net margin 14.88% 11.24% 12.78% 14.5% 12.14% 9.52% 11.35% 8.7% 10% 13.91% 9.47% 10.48% 12.05% 11.29% 12.47% 11.08% 12.55% 13.11% 13.01% 12.68%
EPS 2 30.72 21.10 14.60 33.06 14.36 11.32 14.80 11.88 26.68 19.94 12.88 15.14 18.50 33.64 20.03 17.84 20.26 21.57 23.66 21.92
Dividend per Share 2 7.000 7.000 8.000 8.000 - 9.000 - - 9.500 - - - 11.00 11.00 - 11.00 - 13.00 - 13.00
Announcement Date 07/11/19 05/11/20 04/11/21 04/11/21 09/02/22 12/05/22 09/08/22 10/11/22 10/11/22 09/02/23 15/05/23 09/08/23 14/11/23 14/11/23 07/02/24 14/05/24 - - - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,02,153 79,296 59,799 20,745 44,615 23,331 - -
Net Cash position 1 - - - - - - 52,981 1,25,299
Leverage (Debt/EBITDA) 0.678 x 0.4866 x 0.3926 x 0.1186 x 0.2379 x 0.1096 x - -
Free Cash Flow 1 32,726 27,969 44,277 63,013 58,415 67,904 84,900 1,06,090
ROE (net income / shareholders' equity) 12.7% 11.7% 9.6% 9.5% 8.4% 8.7% 9.32% 10.3%
ROA (Net income/ Total Assets) 9.34% 9.01% 7.49% 8.11% 7.55% 8.2% 7.56% 7.84%
Assets 1 8,51,025 9,45,282 10,31,943 10,95,564 11,82,898 12,96,781 16,76,032 18,58,417
Book Value Per Share 2 470.0 502.0 567.0 669.0 746.0 894.0 946.0 963.0
Cash Flow per Share 2 84.50 92.00 86.90 97.70 106.0 123.0 132.0 144.0
Capex 1 60,845 89,510 77,208 69,230 75,774 78,426 90,558 87,472
Capex / Sales 10.15% 14.23% 12.58% 9.84% 9.24% 8.51% 9.14% 8.21%
Announcement Date 09/05/19 18/05/20 12/05/21 12/05/22 15/05/23 14/05/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Terumo Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,702 JPY
Average target price
3,082 JPY
Spread / Average Target
+14.05%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.26% 187B
MEDTRONIC PLC Stock Medtronic plc
+2.05% 110B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-1.31% 69.54B
CENCORA, INC. Stock Cencora, Inc.
+14.65% 46.37B
DEXCOM, INC. Stock DexCom, Inc.
-6.69% 46.05B
HOYA CORPORATION Stock Hoya Corporation
+7.97% 42.54B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+18.60% 30.72B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-6.87% 23.32B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-10.63% 22.92B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 4543 Stock
  4. TRUMY Stock
  5. Financials Terumo Corporation